Clinical Trials Directory

Trials / Unknown

UnknownNCT05010044

MBCT for Psoriasis Patients With Anxiety and Depression

Mindfulness-based Cognitive Therapy for Psoriasis Patients With Anxiety and Depression

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study investigates the effectiveness of a 24-week mindfulness intervention in reducing symptoms in psoriasis patients with anxiety and depression.

Detailed description

An adapted MBCT intervention will be offered to people with psoriasis with depression and/or anxiety. 8-week long MBCT therapy will be held between August 2021 and Jan 2022, based on the adapted protocol. The MBCT intervention will consist of 30-minute weekly groups focused on teaching mindfulness techniques and ways to recognize cognitive patterns that can increase anxiety and/or depression. Participants will be recruited from the community, according to the eligibility criteria detailed below. For all participants, anxiety and/or depressive symptom severity(SAS/SDS), PASI,DLQI,(as measured with standardized, validated scales) will be compared baseline and weeks 2;4;8;12;16;20;24. Itch intensity ,itch perception ,quality of sleep, hours missing at work ,helpfulness of common itch therapies serve as the secondary outcome, using a paired t-test.

Conditions

Interventions

TypeNameDescription
BEHAVIORALmindfulness-based cognitive therapy (MBCT)Mindfulness- Based Cognitive Therapy (MBCT) It involves practicing to be present 'in the moment' and an attitude of non- judgmental acceptance with the aim to maintain awareness, disengaging oneself from strong attachment and thereby developing a greater sense of emotional balance and well-being.
OTHERAntipsoriatic treatmentThe routine drug therapy for psoriasis.

Timeline

Start date
2021-08-01
Primary completion
2022-01-01
Completion
2022-01-01
First posted
2021-08-18
Last updated
2021-08-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05010044. Inclusion in this directory is not an endorsement.